IRIS PubliCatt

Cammarota, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.818
NA - Nord America 8.090
AS - Asia 2.201
SA - Sud America 35
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 29
OC - Oceania 14
Totale 21.218
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.018
DE - Germania 5.016
SE - Svezia 1.465
CN - Cina 1.301
IT - Italia 1.172
UA - Ucraina 815
FR - Francia 485
IE - Irlanda 457
GB - Regno Unito 442
SG - Singapore 372
PL - Polonia 313
FI - Finlandia 210
IN - India 190
RU - Federazione Russa 186
TR - Turchia 139
BE - Belgio 70
JP - Giappone 56
CA - Canada 54
NL - Olanda 39
ES - Italia 35
IR - Iran 31
CZ - Repubblica Ceca 27
EU - Europa 27
HK - Hong Kong 24
CH - Svizzera 23
BR - Brasile 21
VN - Vietnam 14
AT - Austria 13
AU - Australia 12
RO - Romania 12
KR - Corea 11
PK - Pakistan 11
CI - Costa d'Avorio 10
IL - Israele 10
TN - Tunisia 10
MX - Messico 9
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
HR - Croazia 5
BZ - Belize 4
CO - Colombia 4
LK - Sri Lanka 4
NO - Norvegia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
PH - Filippine 3
RS - Serbia 3
ZA - Sudafrica 3
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
IQ - Iraq 2
KW - Kuwait 2
LT - Lituania 2
MK - Macedonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
YE - Yemen 2
A1 - Anonimo 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
CU - Cuba 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
GL - Groenlandia 1
KZ - Kazakistan 1
MC - Monaco 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
QA - Qatar 1
SC - Seychelles 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 21.218
Salva come PNG Salva come JPEG
Città #
Chandler 1.774
Ashburn 665
Jacksonville 482
Dublin 454
San Mateo 381
Nürnberg 378
Ann Arbor 359
Nanjing 296
Woodbridge 229
Wilmington 224
Warsaw 220
Singapore 212
Boston 199
Cattolica 183
Dearborn 167
Marseille 166
New York 166
Milan 157
Princeton 152
Rome 140
Fairfield 136
Izmir 129
Redwood City 124
Moscow 123
Munich 121
Seattle 119
Houston 114
Nanchang 111
Beijing 109
Lawrence 88
Kraków 75
Shenyang 73
Boardman 66
Hangzhou 66
Fuzhou 65
Los Angeles 65
Brussels 63
Redmond 59
Bremen 56
Hebei 56
Mountain View 54
Verona 54
Lancaster 53
Leawood 52
Chicago 51
Kunming 47
University Park 44
Zhengzhou 44
Pune 43
Cambridge 40
Changsha 40
Shanghai 40
Tianjin 40
Helsinki 38
Guangzhou 37
Norwalk 37
Fremont 36
Jiaxing 32
Augusta 29
Falls Church 29
Las Vegas 29
Jinan 23
London 21
Detroit 19
Kish 16
Washington 16
Andover 15
Edinburgh 15
Hong Kong 15
Lanzhou 14
San Jose 14
Costa Mesa 13
Ottawa 13
Simi Valley 13
Brno 12
Paris 12
San Francisco 12
Toronto 12
Busto Arsizio 11
Ningbo 11
Phoenix 11
Abidjan 10
Hefei 10
Parma 10
San Diego 10
Taizhou 10
Tokyo 10
Trieste 10
Genoa 9
Hanoi 9
Indiana 9
Lappeenranta 9
Seoul 9
Vienna 9
Xian 9
Zurich 9
Amsterdam 8
Changchun 8
Chengdu 8
Monmouth Junction 8
Totale 10.153
Salva come PNG Salva come JPEG
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 443
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 377
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 374
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 356
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 292
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 249
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 205
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 199
Wheat desensitization treatment in patients with gluten sensitivity 198
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 194
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 188
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 186
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 180
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 176
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 173
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 173
-High prevalence of celiac disease in patients with lactose intolerance 170
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 168
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 158
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 152
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 152
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 151
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 151
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 150
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 143
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 142
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 141
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 138
The role of diet on gut microbiota composition 137
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 130
. Adverse reactions to food: allergies and intolerances. 129
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 129
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 129
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 128
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 128
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 127
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 126
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 126
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 125
Can chronic gastritis cause increase of fecal calprotectin concentrations? 124
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 124
Fecal microbiota transplantation: Past, present and future perspectives 122
(gc)Association of laryngeal cancer with previous gastric resection. 121
Celiac disease: what's new about it? 120
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 120
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 119
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 119
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 117
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 117
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 115
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 115
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 115
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 114
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 114
gc) Tired legs a gut diagnosis 113
[Helicobacter pylori infection: from gastric to systemic disease] 112
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 112
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 111
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 109
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 108
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 107
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 107
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 107
(gc) Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study 106
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 106
A) Association of laryngeal cancer with previous gastric resection 105
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 105
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 103
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 103
Faecal calprotectin concentrations in untreated coeliac patients 103
Celiac disease and chronic urticaria resolution: a case report. 103
Levofloxacin based regimens for the eradication of Helicobacter pylori 102
gastroesophageal reflux disease: facts and uncertaines 102
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 102
Classification of malabsorption syndromes. 101
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 100
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 100
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 100
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 100
Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection 99
Reflux symptoms in wind instrument players. 98
Moderately Severe Acute Pancreatitis Associated With Riluzole 97
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 96
Microscopic colitis 96
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 95
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 95
Gluten-related Recurrent Peripheral Facial Palsy 95
Recent insights in primary immunodeficiency diseases: the role of T-lymphocytes and innate immunity. 95
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 95
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 94
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 94
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 94
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 93
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 93
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 92
An Attempt of Specific Desensitizing Treatment with Gliadin in Coleliac Disease 92
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 91
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 90
Role of N-acetyl-cisteine in the treatment of H. pylori 89
Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease 89
Totale 13.568
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.696 0 243 207 191 268 311 425 129 209 202 310 201
2020/20212.100 113 235 52 192 269 170 230 54 233 91 394 67
2021/20222.089 117 184 57 129 130 89 39 336 97 95 387 429
2022/20234.881 627 658 365 732 320 599 247 386 596 94 159 98
2023/20242.633 133 702 87 172 118 318 175 95 69 156 321 287
2024/2025209 148 61 0 0 0 0 0 0 0 0 0 0
Totale 21.534